DCN and breast carcinoma: Our findings are in accordance with earlier reports where adenovirus-mediated decorin gene delivery inhibited the proliferation of colon and squamous carcinoma [52], urothelial malignancies [39], prostate cancer [53], breast cancer bone metastases [51] and pancreatic tumor [54].